Vir Biotechnology Inc.

NAS: VIR

GO
/marketstate/country/us

After Hours

VIR
/zigman2/quotes/214486077/composite

$

40.90

Change

-0.88 -2.11%

Volume

Volume 43,178

Mar 3, 2021, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/214486077/composite

Today's close

$ 57.74

$ 41.78

Change

-15.96 -27.64%

Day low

Day high

$37.37

$44.44

Open
Open: 41.00

52 week low

52 week high

$25.31

$141.01

Open

Market cap

$7.38B

Average volume

1.94M

P/E ratio

N/A

Rev. per Employee

$233,541

EPS

-2.49

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/vir

MarketWatch News on VIR

  1. Stocks Close Lower as Bond Yields Creep Higher

    4:36 p.m. Today

    - Barron's Online

  2. Vir Shares Plummeted Today. What to Know.

    2:58 p.m. Today

    - Barron's Online

  3. Vir and GSK Will Collaborate on Flu Therapy

    9:31 a.m. Feb. 17, 2021

    - Barron's Online

  4. Vir, GSK ink new R&D deal

    8:10 a.m. Feb. 17, 2021

    - Jaimy Lee

  5. Vir Biotechnology downgraded to underweight from neutral at J.P. Morgan

    8:07 a.m. Jan. 27, 2021

    - Tomi Kilgore

  6. GlaxoSmithKline, Lilly, Vir in COVID therapy pact

    6:47 a.m. Jan. 27, 2021

    - MarketWatch.com

  7. Lilly Serves Up an Anti-Covid Cocktail, Like Regeneron’s

    12:44 p.m. Oct. 7, 2020

    - Barron's Online

  8. Stocks Are Going Nowhere Amid Covid-19, Stimulus Concerns

    10:55 a.m. Oct. 6, 2020

    - Barron's Online

  9. Regeneron Says Antibodies Helped Covid Patients Recover Faster

    9:58 p.m. Sept. 29, 2020

    - Barron's Online

  10. The Pandemic Speeds Up the Health-Care Revolution

    5:01 p.m. Oct. 6, 2020

    - Barron's Online

  11. It’s Likely Too Late for Regeneron’s Virus Treatment

    9:00 a.m. Sept. 11, 2020

    - Barron's Online

  12. Loading more headlines...
/news/nonmarketwatch/company/us/vir

Other News on VIR

  1. Vir slide deepens following concerns about VIR-7831 for COVID-19

    3:54 p.m. Today

    - Seeking Alpha

  2. VIR Stock: Why Vir Biotechnology Is Plunging Today

    2:58 p.m. Today

    - InvestorPlace.com

  3. FUBO, RKT, TRXC and SOS among midday movers

    1:00 p.m. Today

    - Seeking Alpha

  4. Vir Bio, GSK recommended to close enrollment in ACTIV-3 trial in COVID-19

    9:18 a.m. Today

    - Seeking Alpha

  5. 10-K: VIR BIOTECHNOLOGY, INC.

    5:13 p.m. Feb. 25, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  6. Despite Q4 2020 earnings misses, Vir's pipeline shows promise

    4:50 p.m. Feb. 25, 2021

    - Seeking Alpha

  7. Company News for Feb 18, 2021

    9:47 a.m. Feb. 18, 2021

    - Zacks.com

  8. AQMS, VIR, SOS and WBAI among premarket gainers

    8:24 a.m. Feb. 17, 2021

    - Seeking Alpha

  9. Vir Biotechnology: Riding The COVID-19 Wave

    8:59 a.m. Feb. 5, 2021

    - Seeking Alpha

  10. GTE, USEG, BB and AMC among midday movers

    12:43 p.m. Jan. 28, 2021

    - Seeking Alpha

  11. Lilly (LLY) Partners Vir/Glaxo for COVID-19 Combo Regimen

    10:28 a.m. Jan. 28, 2021

    - Zacks.com

  12. TTOO, NOK, RIG and PBI among midday movers

    12:41 p.m. Jan. 27, 2021

    - Seeking Alpha

  13. Loading more headlines...
/news/pressrelease/company/us/vir

Press Releases on VIR

  1. Are These The Top Biotech Stocks To Watch Ahead Of February 2021?

    4:07 p.m. Feb. 24, 2021

    - StockMarket.com

  2. Wednesday's ETF with Unusual Volume: MOON

    12:04 p.m. Feb. 17, 2021

    - MarketNewsVideo.com

  3. These Two Drug Stocks are On Sale: Pfizer and GlaxoSmithKline

    6:45 a.m. Dec. 31, 2020

    - Baystreet.ca

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.